Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Metagenomics In Healthcare Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The metagenomics in healthcare market size has witnessed rapid expansion in recent years. It is projected to increase from $2.44 billion in 2025 to $2.87 billion in 2026, displaying a compound annual growth rate (CAGR) of 17.8%. The growth observed in the historical period can be attributed to advancements in sequencing technologies, a rise in the incidence of infectious diseases, the expansion of microbiome research programs, increasing demand for culture-independent diagnostics, and the availability of clinical-grade sequencing workflows.
The metagenomics in healthcare market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $5.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.5%. This anticipated growth during the forecast timeframe is driven by factors such as the increasing implementation of precise infectious disease diagnostics, greater capital allocation towards microbiome therapeutics, the widening scope of genomic epidemiology programs, the expanding integration of AI in microbial analysis, and a heightened emphasis on individualized treatment approaches. Key developments expected within this period encompass the growing acceptance of metagenomic diagnostics in healthcare environments, the expanding application of microbiome-based disease profiling, the accelerating incorporation of NGS in managing infections, the broadening of research into personalized microbial therapeutics, and an elevated concentration on quickly identifying pathogens.
Get A Free Sample Report With In-Depth Market Insights:
Metagenomics In Healthcare Market Growth Drivers: What’s Behind The Acceleration?
The expanding occurrence of infectious diseases is projected to fuel the advancement of the metagenomics in healthcare market moving ahead. Infectious illnesses are conditions resulting from detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can be transmitted between individuals through direct or indirect contact. The growing spread of infectious diseases is attributable to increased global travel, which facilitates the swift dissemination of disease-causing agents across national boundaries. Metagenomics in healthcare assists in combating these diseases by allowing for prompt and accurate identification of pathogens, thus playing a vital role in managing infectious outbreaks. It lessens diagnostic ambiguity by examining intricate microbial populations, thereby enhancing patient results and guiding specific treatments. For instance, in February 2024, the UK Health Security Agency, a UK-based government agency, reported that tuberculosis (a contagious bacterial infection that primarily affects the lungs) instances in England climbed to 4,850 in 2023, marking an increase of 10.7% from 4,380 cases recorded in 2022. Consequently, the rising frequency of infectious diseases is propelling the expansion of the metagenomics in healthcare market.
Metagenomics In Healthcare Market Segment Landscape: Which Areas Lead Development?
The metagenomics in healthcare market covered in this report is segmented –
1) By Types: Sample Extraction Kits, Metagenomics Kits
2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray
3) By Workflow: Sample Collection, Deoxyribonucleic Acid Extraction, Library Preparation, Sequencing
4) By Application: Infectious Disease Diagnosis, Genomic Epidemiology, Personalized Medicine, Microbiome Analysis, Drug Discovery
5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Biotechnology Companies
Subsegments:
1) By Sample Extraction Kits: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Protein Extraction Kits
2) By Metagenomics Kits: Library Preparation Kits, Sequencing Kits, Target Enrichment Kits
Metagenomics In Healthcare Market Trends: What’s Defining The Industry’s Next Phase?
Major companies operating in the metagenomics in healthcare market are prioritizing the development of innovative solutions, such as microbial community profiling, to improve disease diagnostics, enable personalized therapies, and advance precision medicine. Microbial community profiling entails the comprehensive analysis and characterization of diverse microbial populations within a specific environment or sample, utilizing sequencing and bioinformatics tools to identify their composition, diversity, and functional roles. For instance, in August 2024, MGI Tech Co. Ltd., a China-based biotechnology company, introduced a Human Microbiome Metagenomics Sequencing Package to further microbial research and healthcare applications. This package offers an automated, end-to-end microbial community profiling workflow for effectively analyzing human microbiome diversity, function, and disease links using validated high-throughput platforms. It minimizes manual labor, enhances reproducibility, and reduces costs, thereby making large-scale and clinical microbiome research more accessible. Researchers gain advantages from swift and precise microbial identification, alongside adaptable throughput, facilitating biomarker discovery and advancing translational health research.
Metagenomics In Healthcare Market Industry Leaders And Competitive Landscape
Major companies operating in the metagenomics in healthcare market are F. Hoffmann-La Roche AG, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Corporation, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., MedGenome Labs Limited, Zymo Research Corporation, BaseClear B.V., Psomagen Inc., Karius Inc., Microsynth AG, Macrogen Inc., Norgen Biotek Corp., Tiny Health Inc., CosmosID Inc., Kanvas Biosciences Inc., Phase Genomics Inc., Wobble Genomics Inc.
View The Full Metagenomics In Healthcare Market Report:
Metagenomics In Healthcare Market Geographic Spread And Regional Opportunities
North America was the largest region in the metagenomics in healthcare market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenomics in healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
